MUTYH may contribute to the development of sporadic ovarian cancer via the well-described “incessant ovulation” hypothesis [53], “gonadotropin hypothesis” [54], or serous tubal intraepithelial carcinoma (STIC) hypothesis [55]. Here, MUTYH is linked to ovarian carcinoma.